专利检索 ap:("NEURON23, INC.") AND inv:"Kejia Wu" 第 1 页

1.

发明公开
LRRK2 INHIBITORS AND USES THEREOF 审中-公开

公开(公告)号：US20240208972A1

公开(公告)日：2024-06-27

申请号：US18512306

申请日：2023-11-17

申请人： NEURON23, INC.

发明人： Ming Yu , Gyanendra Kumar , Zhonghua Pei , Scott Savage , Kejia Wu , Jim X. Zheng

IPC分类号： C07D471/14 , C07D471/22 , C07D487/04 , C07D519/00

CPC分类号： C07D471/14 , C07D471/22 , C07D487/04 , C07D519/00

摘要： The invention provides compounds that modulate the activity of protein kinases that are associated with human diseases, disorders, and conditions. In particular, compounds of the invention inhibit LRRK2.

2.

发明公开
KINASE MODULATORS AND METHODS OF USE THEREOF 审中-公开

公开(公告)号：US20240174647A1

公开(公告)日：2024-05-30

申请号：US18375063

申请日：2023-09-29

申请人： NEURON23, INC.

发明人： Kejia Wu , Abbas Abdoli , Daniel Guay , Abdelkhalek Ben Jamaa , Gyanendra Kumar , Zhonghua Pei , Ryan Simard , Arkadii Vaisburg , Ming Yu

IPC分类号： C07D403/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D487/04 , C07D498/04

CPC分类号： C07D403/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D487/04 , C07D498/04

摘要： The invention provides compounds that modulate the activity of protein kinases that are associated with human diseases, disorders, and conditions. In particular, compounds of the invention inhibit LRRK2.